Alzheimer's Drug Discovery Foundation Releases 2021 Clinical Trials Report in Conjunction with 14th Annual CTAD Conference

/PRNewswire/ -- A more robust pipeline of novel targets spanning all clinical trial phases and an ongoing focus on therapeutics driven by the biology of aging...

Related Keywords

Boston ,Massachusetts ,United States ,Howard Fillit ,Ronalds Lauder ,Bill Gates ,Research To Commercialization ,Alzheimer Drug Discovery Foundation ,Drug Discovery Foundation ,Trials Report ,Annual Clinical Trials ,Disease Conference ,Founding Executive Director ,Chief Science Officer ,Diagnostics Accelerator ,Gates Notes ,Funded Investigators ,Placebo Controlled Phase ,Digital Therapeutics ,Mild Cognitive Impairment ,New Pathway ,Bringing Repurposed Drugs ,First Trial Targeting Reduction ,Hippocampal Overactivity ,Treat Mild Cognitive Impairment ,Value Generating Exploratory Trials ,Neurodegenerative Dementias ,Drug Discovery ,Alzheimer 39s Drug Discovery Foundation ,